Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$7.95 - $18.81 $61,159 - $144,705
-7,693 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$6.45 - $14.04 $38,732 - $84,310
6,005 Added 355.75%
7,693 $77,000
Q4 2019

Feb 06, 2020

BUY
$12.97 - $15.94 $21,893 - $26,906
1,688 New
1,688 $23,000
Q3 2019

Nov 07, 2019

SELL
$14.75 - $20.87 $44,486 - $62,943
-3,016 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$14.71 - $19.79 $44,365 - $59,686
3,016 New
3,016 $59,000
Q2 2018

Jul 24, 2018

SELL
$14.8 - $18.8 $128,774 - $163,578
-8,701 Closed
0 $0
Q1 2018

Apr 12, 2018

BUY
$14.5 - $23.4 $126,164 - $203,603
8,701 New
8,701 $163,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.